TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12667380

Group type: EXPERIMENTAL
Intervention: Folic acid (FA, 20 mg per day plus vitamin B(12) 1 mg, intramuscularly, per month for one year, then 20 mg two times a week plus 1 mg per three months for the next year)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Natural beta-carotene (N-betaC, 30 mg per day for first year, then 30 mg two times a week for the next)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Synthetic beta-carotene (S-betaC, administered as in N-betaC)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 10382572

Group type: EXPERIMENTAL
Intervention: Test varnish containing 1% chlorhexidine and 1% thymol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo varnish (control) consisting of ethanol, ethylacetate and polyvinylbutyral
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Test varnish
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo varnish (control)
Number of subjects: 20
Study: 8694046

Group type: EXPERIMENTAL
Intervention: Misoprostol alone (200 micrograms administered vaginally every 12 hours)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Misoprostol with laminaria (200 micrograms administered vaginally every 12 hours with intracervical placement of laminaria)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Misoprostol alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Misoprostol with laminaria
Number of subjects: 68
Study: 1805818

Group type: EXPERIMENTAL
Intervention: rubidazone (zorubicin) 200 mg/m2/d, days 1 to 4 plus cytarabine (Ara C) 200 mg/m2/d, days 1 to 7 (arm A)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: amsacrine (Amsa) 150 mg/m2/d, days 1 to 4 plus Ara C 200 mg/m2/d, days 1 to 7 (arm B)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: arm A (rubidazone + Ara C)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: arm B (amsacrine + Ara C)
Number of subjects: 39
Study: 6460974

Group type: EXPERIMENTAL
Intervention: mezlocillin (1 g, intravenously)
Number of subjects: 10

Group type: COMPARATOR
Intervention: ampicillin (1 g, intravenously)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: mezlocillin (1 g, intramuscularly)
Number of subjects: 10

Group type: COMPARATOR
Intervention: ampicillin (1 g, intramuscularly)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: mezlocillin (1 g, intramuscularly) with probenecid (1 g, orally)
Number of subjects: 10
Study: 29976648

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27938960

Group type: EXPERIMENTAL
Intervention: narrated white board animation (nWBA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: standard physician‐patient interaction
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: both standard and nWBA consent
Number of subjects: 78
Study: 25115748

Group type: EXPERIMENTAL
Intervention: Behavioral therapy alone or combined with contingency management
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (healthy comparison individuals)
Number of subjects: 23
Study: 22837058

Group type: EXPERIMENTAL
Intervention: 1,470 nm diode laser (contact mode, 15 W power)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Carbon dioxide laser (12 W power)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 21
Study: 21188919

Group type: EXPERIMENTAL
Intervention: CHX
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CHX+NaF+ZnCl2
Number of subjects: 24
Study: 18534821

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 246

Group type: COMPARATOR
Intervention: Perphenazine vs. Olanzapine
Number of subjects: 246

Group type: COMPARATOR
Intervention: Perphenazine vs. Quetiapine
Number of subjects: 246
Study: 16313121

Group type: EXPERIMENTAL
Intervention: Zhenggan Recipe (ZGR)
Number of subjects: 64
Study: 15557529

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11789240

Group type: EXPERIMENTAL
Intervention: Tripterygium polyglycoside (TP)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Adrenal corticosteroid
Number of subjects: 43
Study: 9586486

Group type: EXPERIMENTAL
Intervention: ICAGD occlusal adjustments to shorten disclusion time to less than .5 seconds per mandibular excursion (10 subjects)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Mock ICAGD with tooth polishing (8 subjects)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No treatment (untreated group)
Number of subjects: 25
Study: 8456754

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 1387
Study: 3510612

Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride (0.5%)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Timolol maleate (0.5%)
Number of subjects: 29
Study: 30183208

Group type: EXPERIMENTAL
Intervention: Alprostadil (10 μg, once daily) and calcium dobesilate (0.5 g, 3 times daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Alprostadil (10 μg, once daily)
Number of subjects: 120
Study: 26717493

Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy (20-60 or 80-120 mg/day)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Lurasidone adjunctive therapy (20-120 mg/day)
Number of subjects: 639
Study: 23690000

Group type: EXPERIMENTAL
Intervention: High-reward pictures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-reward pictures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate recognition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 24-hour study-test delay
Number of subjects: 0
Study: 23055489

Group type: EXPERIMENTAL
Intervention: Dopamine precursor levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 20542272

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 72
Study: 18446716

Group type: EXPERIMENTAL
Intervention: AST-120 (6.0 g daily for 12 months) plus low-protein diet and RAS blocker therapy (group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Not applicable (group B, no AST-120)
Number of subjects: 28
Study: 16164489

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (64 mmol/day intravenously)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 94
Study: 14674665

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg twice daily, clarithromycin 250 mg twice daily, metronidazole 500 mg twice daily for 4 days (n = 63)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Rabeprazole 20 mg twice daily, clarithromycin 250 mg twice daily, metronidazole 500 mg twice daily for 7 days (n = 65)
Number of subjects: 128
Study: 10223594

Group type: EXPERIMENTAL
Intervention: Immediate (IMM) zidovudine therapy
Number of subjects: 297

Group type: COMPARATOR
Intervention: Deferred (DEF) zidovudine therapy
Number of subjects: 297
Study: 7884546

Group type: EXPERIMENTAL
Intervention: Soycreme administration
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no soycreme)
Number of subjects: 36
Study: 2203249

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) injections (0.1 mg/kg ideal body weight every other day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle injections (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) injections
Number of subjects: 8
Study: 213374

Group type: EXPERIMENTAL
Intervention: Total mastectomy with postoperative irradiation
Number of subjects: 1539

Group type: COMPARATOR
Intervention: Total mastectomy without postoperative irradiation
Number of subjects: 1539

Group type: EXPERIMENTAL
Intervention: Radical mastectomy
Number of subjects: 1539

Group type: EXPERIMENTAL
Intervention: Treatment overall (including all types)
Number of subjects: 1539

Group type: EXPERIMENTAL
Intervention: Tumor necrosis
Number of subjects: 1539

Group type: EXPERIMENTAL
Intervention: Tumor size < 5 cm
Number of subjects: 1539
Study: 31228197

Group type: EXPERIMENTAL
Intervention: Theory-based social-cognitive intervention (4 weekly 1-hr face-to-face sessions)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Active control group (parallel sessions targeting physical activity)
Number of subjects: 264
Study: 29150995

Group type: EXPERIMENTAL
Intervention: Venous PTA
Number of subjects: 115

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 115
Study: 27228110

Group type: EXPERIMENTAL
Intervention: Patching (mean 3.73 hours/day in the first year, 3.43 hours/day thereafter)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 109
Study: 23944980

Group type: EXPERIMENTAL
Intervention: Bilateral paramedian (double needle) technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unilateral paramedian (single needle) technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 60
Study: 21404089

Group type: EXPERIMENTAL
Intervention: Slow up-titration of paroxetine (arm A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard up-titration of paroxetine (arm B)
Number of subjects: 30
Study: 20061165

Group type: EXPERIMENTAL
Intervention: Nebulized liposomal amphotericin B (n-LAB)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Nebulized amphotericin B deoxycholate (n-ABD)
Number of subjects: 104
Study: 18545177

Group type: EXPERIMENTAL
Intervention: Static and dynamic stretching
Number of subjects: 11

Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 11

Group type: COMPARATOR
Intervention: Dynamic stretching
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Combined static and dynamic stretching
Number of subjects: 11

Group type: COMPARATOR
Intervention: No stretching
Number of subjects: 11
Study: 15925125

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14601158

Group type: EXPERIMENTAL
Intervention: Designed data RCTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine data RCTs
Number of subjects: 0
Study: 10523736

Group type: EXPERIMENTAL
Intervention: Anger-inducing situation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Non-anger-inducing situation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 52
Study: 7734295

Group type: EXPERIMENTAL
Intervention: Chemotherapy with cyclophosphamide, epirubicin and fluorouracil
Number of subjects: 81

Group type: COMPARATOR
Intervention: DNA ploidy
Number of subjects: 81
Study: 2281427

Group type: EXPERIMENTAL
Intervention: Inhaled micronised gentamicin powder (180 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nebulised gentamicin solution (160 mg)
Number of subjects: 40
Study: 7435264

Group type: EXPERIMENTAL
Intervention: Metoprolol, 100 mg b.i.d.
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 6219912

Group type: EXPERIMENTAL
Intervention: 5 g Meclocillin (single dose)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no Meclocillin)
Number of subjects: 100
Study: 30401608

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU monthly for 24 months)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Maintaining vitamin D sufficiency
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 413
Study: 29614897

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS) plus dietary counselling (DC)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control (dietary counselling alone)
Number of subjects: 255
Study: 26864092

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg once daily
Number of subjects: 6595

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6595
Study: 25238785

Group type: EXPERIMENTAL
Intervention: Single oral dose of corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed antibiotic prescription or no antibiotic prescription (control)
Number of subjects: 0
Study: 23185303

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV-7)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control villages (infants aged 2-30 months receiving Meningococcal C conjugate vaccine)
Number of subjects: 328
Study: 20098137

Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine (basal 12 ml/h, bolus 4 ml)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.4% ropivacaine (basal 3 ml/h, bolus 1 ml)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (0.1% and 0.4% ropivacaine)
Number of subjects: 50
Study: 17363337

Group type: EXPERIMENTAL
Intervention: Alprazolam (1 mg) in patients with panic disorder
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alprazolam (1 mg) in healthy controls
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo in healthy controls
Number of subjects: 30
Study: 16278615

Group type: EXPERIMENTAL
Intervention: 1.0 mg of estradiol plus 2.0 mg of drospirenone (DRSP/E(2))
Number of subjects: 1147

Group type: COMPARATOR
Intervention: 1.0 mg of estradiol alone (E(2) monotherapy)
Number of subjects: 1147

Group type: EXPERIMENTAL
Intervention: Drospirenone and estradiol combinations
Number of subjects: 1147

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1147

Group type: EXPERIMENTAL
Intervention: Drospirenone combined with estradiol
Number of subjects: 1147
Study: 12086758

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Non-HAART
Number of subjects: 1034
Study: 9565058

Group type: EXPERIMENTAL
Intervention: Indocyanine green staining of the anterior capsule
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard circular continuous capsulorrhexis
Number of subjects: 20
Study: 7622910

Group type: EXPERIMENTAL
Intervention: IL-1 receptor antagonist (IL-1ra)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escherichia coli infusion
Number of subjects: 0
Study: 2694741

Group type: EXPERIMENTAL
Intervention: Cefuroxim (1.5 g intravenous bolus at the beginning of and 12 hours after the operation)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (intravenous bolus at the beginning of and 12 hours after the operation)
Number of subjects: 80
Study: 375684

Group type: EXPERIMENTAL
Intervention: Mianserin (60 mg daily for four weeks)
Number of subjects: 50
Study: 31153659

Group type: COMPARATOR
Intervention: Advice alone
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Established lifestyle intervention (physical activity, sodium reduction, weight loss)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Established + DASH lifestyle intervention (DASH diet counseling)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Every 10-session increase in counseling
Number of subjects: 756
Study: 28550081

Group type: EXPERIMENTAL
Intervention: Calcifediol (5000 IU 25-hydroxyvitamin D3), thrice weekly for 6 months
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 µg 1,25-dihydroxyvitamin D3), thrice weekly for 6 months
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo, thrice weekly for 6 months
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Combined vitamin D treatment (calcifediol and calcitriol)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Combined vitamin D treatment
Number of subjects: 119
Study: 26560487

Group type: EXPERIMENTAL
Intervention: Transdermal 4-hydroxytamoxifen (4-OHT) gel applied daily to the axillary mammary gland for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal endoxifen gel applied daily to the axillary mammary gland for 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal telapristone acetate gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclofenac patch applied to the breast skin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac patch applied to the abdominal skin
Number of subjects: 0
Study: 23379344

Group type: EXPERIMENTAL
Intervention: Fractional microplasma RF
Number of subjects: 33

Group type: COMPARATOR
Intervention: CO2 FS
Number of subjects: 33
Study: 21184267

Group type: EXPERIMENTAL
Intervention: Promotora-administered educational intervention
Number of subjects: 381

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 381
Study: 19361781

Group type: EXPERIMENTAL
Intervention: Problem-solving training (PST) intervention group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Education-only control group
Number of subjects: 64
Study: 17708377

Group type: EXPERIMENTAL
Intervention: High-tech (Duo2, Hill Rom) alternating low-pressure mattress
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: High-tech (Duo2, Hill Rom) continuous low-pressure mattress
Number of subjects: 203

Group type: COMPARATOR
Intervention: High-specification foam mattress (control)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: High-tech mattress (alternating vs continuous low pressure)
Number of subjects: 203
Study: 15020517

Group type: EXPERIMENTAL
Intervention: Biatrial pacing
Number of subjects: 23

Group type: COMPARATOR
Intervention: High right atrial pacing (HRA)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Coronary sinus pacing (CS)
Number of subjects: 23
Study: 10799369

Group type: EXPERIMENTAL
Intervention: DHA (4 g daily)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EPA (4 g daily)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both EPA and DHA (4 g daily)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 59
Study: 8831316

Group type: COMPARATOR
Intervention: T 0.5% + E (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: T 1% + E
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: T 0.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: T 1%
Number of subjects: 60
Study: 1388336

Group type: EXPERIMENTAL
Intervention: Intravenous alfentanil bolus dose (30 micrograms/kg) followed by bolus doses of 10 micrograms/kg every 10 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous alfentanil infusion (30 micrograms/kg induction dose over 1 min, followed by infusion at 1.0 micrograms.kg‐1.min‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Incisional procedures
Number of subjects: 40
Study: 3888943

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus mezlocillin
Number of subjects: 60
Study: 31367909

Group type: EXPERIMENTAL
Intervention: Moderate-dose exercise (8 kcal/kg body weight/week)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High-dose exercise (20 kcal/kg body weight/week)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Combined exercise groups (moderate and high-dose)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Non-compensators (participants who lost more weight)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: VO2peak increase
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 137
Study: 29509911

Group type: EXPERIMENTAL
Intervention: LIDΔM2‐2 vaccine (105 PFU, single intranasal dose)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: LIDΔM2‐2 vaccine
Number of subjects: 29
Study: 28832514

Group type: EXPERIMENTAL
Intervention: Avocado (0.5 mg/day lutein)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (potato or chickpeas, 0 mg/day lutein)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Avocado
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 26655803

Group type: EXPERIMENTAL
Intervention: Epinephrine (0.06 mcg.kg(1).min(‐1))
Number of subjects: 81

Group type: COMPARATOR
Intervention: Levosimendan (0.2 mcg.kg(1).min(‐1))
Number of subjects: 81
Study: 23379292

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (20 U)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 20663998

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17693592

Group type: EXPERIMENTAL
Intervention: Distance-based quality improvement intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Paper-based education
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 29
Study: 17052490

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 5% hydrogel/clindamycin 1% lotion + UVA irradiation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fluticasone 0.05% cream + UVA irradiation
Number of subjects: 45
Study: 12709680

Group type: EXPERIMENTAL
Intervention: 5 mg oral folic acid per day
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 15 mg oral folic acid per day
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Treated patients (5 mg and 15 mg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 81
Study: 10781752

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 8827136

Group type: EXPERIMENTAL
Intervention: Centrifuge subjects exposed to 15 s rapid onset (6 G.s‐1) + 5 Gz exposure while wearing a well‐fitting anti‐G suit (pressure inactivated)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tilt/LBNP group (upright tilt and lower body negative pressure at -20 mm Hg and -40 mm Hg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Centrifuge subjects at G-LOC endpoints
Number of subjects: 0
Study: 1571611

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) administered within 8 hours of injury
Number of subjects: 487

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 3907988

Group type: EXPERIMENTAL
Intervention: sulindac (200 mg twice daily)
Number of subjects: 312

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 312
Study: 31246603

Group type: EXPERIMENTAL
Intervention: Prophylactic haloperidol (1 or 2 mg)
Number of subjects: 1789

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 1789
Study: 30251914

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment (14-16J/cm2) combined with Meibomian Gland Expression (MGX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham IPL treatment (0J/cm2)
Number of subjects: 0